×
About 8,508 results

ALLMedicine™ Basal Cell Carcinoma Center

Research & Reviews  2,654 results

High Dose Rate Brachytherapy in non - melanoma skin cancer - systematic review.
https://doi.org/10.1111/dth.15675
Dermatologic Therapy; Krzysztofiak T, Kamińska-Winciorek G et. al.

Jul 1st, 2022 - Non-melanoma skin cancers (NMSC's) are the most common malignancies worldwide. Millions of new cases every year present challenge to healthcare systems. Recent years brought numerous new data concerning High Dose Rate (HDR) brachytherapy as treatm...

Cancer risk and tumour spectrum in 172 patients with a germline SUFU pathogenic variati...
https://doi.org/10.1136/jmedgenet-2021-108385
Journal of Medical Genetics; Guerrini-Rousseau L, Masliah-Planchon J et. al.

Jun 30th, 2022 - Little is known about risks associated with germline SUFU pathogenic variants (PVs) known as a cancer predisposition syndrome. To study tumour risks, we have analysed data of a large cohort of 45 unpublished patients with a germline SUFU PV comple...

Systemic Targeted Treatments for Basal Cell Carcinoma
https://www.mdedge.com/dermatology/article/255899/nonmelanoma-skin-cancer/systemic-targeted-treatments-basal-cell-carcinoma
Steven A. Svoboda, MD, Nathan M. Johnson, MD et. al.

Jun 29th, 2022 - Basal cell carcinoma (BCC) is the most common keratinocyte carcinoma and affects more than 3 million individuals per year in the United States. 1 Approximately 40% of patients diagnosed with BCC will develop another BCC within 5 years of the initia.

Study finds higher risk of skin cancer after childhood organ transplant
https://www.mdedge.com/dermatology/article/255839/nonmelanoma-skin-cancer/study-finds-higher-risk-skin-cancer-after
Christine Kilgore

Jun 28th, 2022 - A large study showing an increased risk of keratinocyte carcinoma (KC) in children who receive a solid-organ transplant highlights the need for early education about risk reduction and more research to determine optimal timing for screening, say a.

see more →

Guidelines  7 results

Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of t...
https://doi.org/10.1016/j.prro.2019.10.014
Practical Radiation Oncology; Likhacheva A, Awan M et. al.

Dec 14th, 2019 - This guideline reviews the evidence for the use of definitive and postoperative radiation therapy (RT) in patients with basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). The American Society for Radiation Oncology convened a...

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdiscipli...
https://doi.org/10.1016/j.ejca.2019.06.003
European Journal of Cancer (Oxford, England : 1990); Peris K, Fargnoli MC et. al.

Jul 10th, 2019 - Basal cell carcinoma (BCC) is the most common malignant tumour in white populations. Multidisciplinary experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European Organization of Research and Treatmen...

Guidelines of care for the management of basal cell carcinoma.
https://doi.org/10.1016/j.jaad.2017.10.006
Journal of the American Academy of Dermatology; , et. al.

Jan 15th, 2018 - Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly cura...

Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873942
The Journal of Laryngology and Otology; Newlands C, Currie R et. al.

Nov 15th, 2016 - This is the official guideline endorsed by the specialty associations involved in the care of head and neck cancer patients in the UK. This paper provides consensus recommendations on the management of cutaneous basal cell carcinoma and squamous c...

Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2016.0065
Journal of the National Comprehensive Cancer Network : JN... Bichakjian CK, Olencki T et. al.

May 11th, 2016 - Basal cell carcinoma (BCC) of the skin is the most common cancer, with a higher incidence than all other malignancies combined. Although it is rare to metastasize, patients with multiple or frequently recurring BCC can suffer substantial comorbidi...

see more →

Drugs  16 results see all →

Clinicaltrials.gov  196 results

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
https://clinicaltrials.gov/ct2/show/NCT00001163

Jun 24th, 2022 - Background: Persons may be prone to develop cancer for a variety of reasons including: inherited predisposition benign, premalignant, or malignant conditions; environmental exposures shared by family members; previous tumors, immune deficiency, or...

The Efficacy and Safety of HLX07 in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)
https://clinicaltrials.gov/ct2/show/NCT05238363

Jun 21st, 2022 - Following basal cell carcinoma, Cutaneous Squamous Cell Carcinoma (CSCC) is the most common skin cancer and its incidence remains on a steady rise. The vast majority of CSCC lesions are treated with surgical resection and have a cure rate exceedin...

A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma
https://clinicaltrials.gov/ct2/show/NCT03534947

Jun 13th, 2022 - Surgery is the first line treatment for most basal cell carcinomas (BCCs) with cure rates of 88 to 96%. However, excision of large lesions in sensitive locations such as the face and scalp may result in disfigurement and impairment of function. Ne...

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma
https://clinicaltrials.gov/ct2/show/NCT04669808

Jun 9th, 2022 - Basal cell carcinoma occurs most often on areas of the skin that are exposed to the sun, such as head and neck. The most commonly found clinical feature of Basal Cell Carcinoma (BCC) is an elevated tumor with a pearly and translucent margin and te...

A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
https://clinicaltrials.gov/ct2/show/NCT05413044

Jun 9th, 2022 - The purpose of this study is to collect real-world data in order to estimate the frequency of overall malignancies, melanoma, basal cell carcinoma, and squamous cell carcinoma in participants with rheumatoid arthritis (RA) or psoriatic arthritis (...

see more →

News  520 results

Study on KC Risk in Pediatric Transplant Recipients Points to Need for Education, More Research
https://www.medscape.com/viewarticle/976417

Jun 30th, 2022 - A large study showing an increased risk of keratinocyte carcinoma (KC) in children who receive a solid-organ transplant highlights the need for early education about risk reduction and more research to determine optimal timing for screening, say a...

Systemic Targeted Treatments for Basal Cell Carcinoma
https://www.mdedge.com/dermatology/article/255899/nonmelanoma-skin-cancer/systemic-targeted-treatments-basal-cell-carcinoma
Steven A. Svoboda, MD, Nathan M. Johnson, MD et. al.

Jun 29th, 2022 - Basal cell carcinoma (BCC) is the most common keratinocyte carcinoma and affects more than 3 million individuals per year in the United States. 1 Approximately 40% of patients diagnosed with BCC will develop another BCC within 5 years of the initia.

Study finds higher risk of skin cancer after childhood organ transplant
https://www.mdedge.com/dermatology/article/255839/nonmelanoma-skin-cancer/study-finds-higher-risk-skin-cancer-after
Christine Kilgore

Jun 28th, 2022 - A large study showing an increased risk of keratinocyte carcinoma (KC) in children who receive a solid-organ transplant highlights the need for early education about risk reduction and more research to determine optimal timing for screening, say a.

Basal Cell Carcinoma
https://www.mdedge.com/dermatology/article/255417/diversity-medicine/basal-cell-carcinoma
Candrice R. Heath, MD, Richard P. Usatine, MD

Jun 14th, 2022 - Photographs courtesy of Richard P. Usatine, MD (Figure A), and Tizita Yosef Kidane, MD (Figure B).

Mohs Surgery in the Elderly: the Dilemma of When to Treat
https://www.medscape.com/viewarticle/974943

Jun 2nd, 2022 - As increasing numbers of patients in their 80s, 90s, and even 100s present for possible Mohs micrographic surgery, surgeons are confronted with deciding when the risks of treatment may outweigh the benefits. Dr Howard Rogers In one of two presenta...

see more →

Patient Education  10 results see all →